This trial studies a new drug to see how safe and effective it is on patients with certain types of cancer.
- Advanced Solid Tumors
- Solid Tumors
- Non-Small Cell Lung Cancer
- Pancreatic Adenocarcinoma
- Colorectal Cancer
6 Primary · 6 Secondary · Reporting Duration: 2 years
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
304 Total Participants · 2 Treatment Groups
Primary Treatment: Phase 2 · No Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still vacancies for participants in this trial?
"This clinical trial is currently recruiting, as reported on clinicaltrials.gov. It first appeared online in March 10th 2023 and has been recently updated on July 3rd of the same year." - Anonymous Online Contributor
How many individuals are currently participating in this experimentation?
"Indeed, the details shared on clinicaltrials.gov point to this ongoing medical trial as actively searching for participants. This study was initially posted on March 10th 2023 and most recently updated on March 7th 2023; it is currently recruiting 304 patients from one location." - Anonymous Online Contributor